Memphis Pharmaceuticals' market value is the price at which a share of Memphis Pharmaceuticals trades on a public exchange. It measures the collective expectations of Memphis Pharmaceuticals investors about its performance. Memphis Pharmaceuticals is trading at 52.72 as of the 22nd of December 2024. This is a 0.40 percent up since the beginning of the trading day. The stock's lowest day price was 51.3. With this module, you can estimate the performance of a buy and hold strategy of Memphis Pharmaceuticals and determine expected loss or profit from investing in Memphis Pharmaceuticals over a given investment horizon. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Symbol
Memphis
Memphis Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Memphis Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Memphis Pharmaceuticals.
0.00
06/25/2024
No Change 0.00
0.0
In 5 months and 30 days
12/22/2024
0.00
If you would invest 0.00 in Memphis Pharmaceuticals on June 25, 2024 and sell it all today you would earn a total of 0.00 from holding Memphis Pharmaceuticals or generate 0.0% return on investment in Memphis Pharmaceuticals over 180 days.
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Memphis Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Memphis Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Memphis Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Memphis Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Memphis Pharmaceuticals historical prices to predict the future Memphis Pharmaceuticals' volatility.
Memphis Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Memphis Pharmaceuticals has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14% return per unit of risk over the last 3 months. By analyzing Memphis Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.99% is justified by implied risk. Please exercise Memphis Pharmaceuticals' Mean Deviation of 3.25, risk adjusted performance of 0.0914, and Downside Deviation of 3.18 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Memphis Pharmaceuticals holds a performance score of 10. The company secures a Beta (Market Risk) of 0.3, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Memphis Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Memphis Pharmaceuticals is expected to be smaller as well. Please check Memphis Pharmaceuticals' sortino ratio, maximum drawdown, and the relationship between the total risk alpha and treynor ratio , to make a quick decision on whether Memphis Pharmaceuticals' current price movements will revert.
Auto-correlation
-0.61
Very good reverse predictability
Memphis Pharmaceuticals has very good reverse predictability. Overlapping area represents the amount of predictability between Memphis Pharmaceuticals time series from 25th of June 2024 to 23rd of September 2024 and 23rd of September 2024 to 22nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Memphis Pharmaceuticals price movement. The serial correlation of -0.61 indicates that roughly 61.0% of current Memphis Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.61
Spearman Rank Test
0.12
Residual Average
0.0
Price Variance
84.62
Memphis Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Memphis Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Memphis Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Memphis Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Memphis Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Memphis Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Memphis Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Memphis Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Memphis Pharmaceuticals stock over time.
Current vs Lagged Prices
Timeline
Memphis Pharmaceuticals Lagged Returns
When evaluating Memphis Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Memphis Pharmaceuticals stock have on its future price. Memphis Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Memphis Pharmaceuticals autocorrelation shows the relationship between Memphis Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Memphis Pharmaceuticals.
Regressed Prices
Timeline
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.